The Emerging Role of Innate Immunity in the Heart and Vascular System
- 29 April 2011
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 108 (9), 1133-1145
- https://doi.org/10.1161/circresaha.110.226936
Abstract
Recent studies suggest that the heart possesses an innate immune system that is intended to delimit tissue injury, as well as orchestrate homoeostatic responses, within the heart. The extant literature suggests that this intrinsic stress response system is mediated, at least in part, by a family of pattern recognition receptors, most notably the Toll-like receptors. Although the innate immune system provides a short-term adaptive response to tissue injury, the beneficial effects of this phylogenetically ancient system may be lost if innate immune signaling becomes sustained and/or excessive; in which case, the salutary effects of activation of these pathways are contravened by the known deleterious effects of inflammatory signaling. Herein, the biology of innate immune signaling in the heart is reviewed, as well as the literature suggesting that the innate immune system is involved in the pathogenesis of atherosclerosis, acute coronary syndromes, stroke, viral myocarditis, sepsis, ischemia/reperfusion injury, and heart failure. The review concludes by discussing new therapies that are being developed to modulate the innate immune system.Keywords
This publication has 82 references indexed in Scilit:
- Therapeutic targeting of innate immunity in the failing heartJournal of Molecular and Cellular Cardiology, 2011
- Unexpected protective role for Toll-like receptor 3 in the arterial wallProceedings of the National Academy of Sciences of the United States of America, 2011
- Cardiomyocyte Toll-like receptor 4 is involved in heart dysfunction following septic shock or myocardial ischemiaJournal of Molecular and Cellular Cardiology, 2010
- Inflammation in AtherosclerosisJournal of the American College of Cardiology, 2009
- Inositol phosphatase SHIP1 is a primary target of miR-155Proceedings of the National Academy of Sciences of the United States of America, 2009
- Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heartAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunityProceedings of the National Academy of Sciences of the United States of America, 2008
- Toll-like receptor signaling in endogenous neuroprotection and strokeNeuroscience, 2008
- NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responsesProceedings of the National Academy of Sciences of the United States of America, 2006
- Toll-like receptor signallingNature Reviews Immunology, 2004